Terms: = Ovarian cancer AND MKL1, BSAC, 57591, ENSG00000196588, Q969V6, MRTF-A
4 results:
1. Genomic landscapes of ovarian clear cell carcinoma from latin countries reveal aberrations linked to survival and progression.
Batista MP; Roffé M; Romero I; López-Guerrero JA; Illueca C; Lopez R; Balieiro Anastácio da Costa AA; De Brot L; Molina JP; Barboza L; Peria FM; Chaud F; Gouvêa Yamada AS; Poveda A; Rego EM
BMC Cancer; 2023 Jul; 23(1):613. PubMed ID: 37400764
[TBL] [Abstract] [Full Text] [Related]
2. mkl1 links epigenetic activation of MMP2 to ovarian cancer cell migration and invasion.
Xu W; Xu H; Fang M; Wu X; Xu Y
Biochem Biophys Res Commun; 2017 Jun; 487(3):500-508. PubMed ID: 28385531
[TBL] [Abstract] [Full Text] [Related]
3. ovarian cancer-derived lysophosphatidic acid stimulates secretion of VEGF and stromal cell-derived factor-1 alpha from human mesenchymal stem cells.
Jeon ES; Heo SC; Lee IH; Choi YJ; Park JH; Choi KU; Park DY; Suh DS; Yoon MS; Kim JH
Exp Mol Med; 2010 Apr; 42(4):280-93. PubMed ID: 20177148
[TBL] [Abstract] [Full Text] [Related]
4. CCG-1423: a small-molecule inhibitor of RhoA transcriptional signaling.
Evelyn CR; Wade SM; Wang Q; Wu M; Iñiguez-Lluhí JA; Merajver SD; Neubig RR
Mol Cancer Ther; 2007 Aug; 6(8):2249-60. PubMed ID: 17699722
[TBL] [Abstract] [Full Text] [Related]
